IMUX (Immunic) Interest Received


IMUX Immunic Inc IMUX
28 GF Score
Price $14.73
! 3 Warning Signs
View Full Analysis

What is Immunic Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.

IMUX
28GF Score
Immunic Inc IMUX
Interest Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Immunic Business Description

Other Exchanges 10V:Germany
Address 1200 Avenue of the Americas, Suite 200, New York, NY, USA, 10036
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function. It operates in one segment which is Life science segment.
28GF Score

Get the complete analysis for IMUX

Interest Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$14.73
Price